Evidence map›Paper›PMID 30442899›Full record

ArticleScientific reports2018

Structural Basis for Binding of Allosteric Drug Leads in the Adenosine A

Yinglong Miao, Apurba Bhattarai, Anh T N Nguyen, Arthur Christopoulos, Lauren T May

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 76 citations in OpenAlex.

  1. From empirical screening to lipid trolling: the evolution of extrahelical allosteric modulators of AMedicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Review
  2. Article
  3. Article
  4. Lipid Trolling to Optimize AJournal of medicinal chemistry · 2024
    Article
  5. Article
  6. Mechanism of Ligand Binding to Theophylline RNA Aptamer.Journal of chemical information and modeling · 2024
    Article
  7. Accelerating Molecular Dynamics Simulations for Drug Discovery.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Deep Learning Dynamic Allostery of G-Protein-Coupled Receptors.bioRxiv : the preprint server for biology · 2023
    Article
  13. Review
  14. The full activation mechanism of the adenosine AProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Mechanism of RNA recognition by a Musashi RNA-binding protein.Current research in structural biology · 2022
    Review
  20. Binding Analysis Using Accelerated Molecular Dynamics Simulations and Future Perspectives.Advances and applications in bioinformatics and chemistry : AABC · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Yinglong MiaoCenter for Computational Biology and Department of Molecular Biosciences, University of Kansas, Lawrence, KS, 66047, USA. miao@ku.edu.
Apurba BhattaraiCenter for Computational Biology and Department of Molecular Biosciences, University of Kansas, Lawrence, KS, 66047, USA.
Anh T N NguyenDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, VIC, 3052, Australia.
Arthur ChristopoulosDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, VIC, 3052, Australia.
Lauren T MayDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, VIC, 3052, Australia.
Monash University · AUUniversity of Kansas · US

Funding

American Heart Association-American Stroke Association 17SDG33370094
6 · The paper itself

Abstract

Despite intense interest in designing positive allosteric modulators (PAMs) as selective drugs of the adenosine A

Indexed as

Adenosine A1 Receptor AgonistsAdenosine A1 Receptor AntagonistsAllosteric RegulationAllosteric SiteBinding SitesMolecular Dynamics SimulationReceptor, Adenosine A1Structure-Activity RelationshipAdenosine A1 Receptor AgonistsAdenosine A1 Receptor AntagonistsReceptor, Adenosine A1

Identifiers

PMID30442899
PMCPMC6237911
OpenAlexW2900145238

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.